PLX: CHMP Delivers Positive Opinion
By John Vandermosten, CFANYSE:PLXREAD THE FULL PLX RESEARCH REPORTCHMP Positive Opinion for Elfabrio Four-Week DosingIn October 2025, Protalix BioTherapeutics, Inc. (NYSE:PLX)...
By John Vandermosten, CFANYSE:PLXREAD THE FULL PLX RESEARCH REPORTCHMP Positive Opinion for Elfabrio Four-Week DosingIn October 2025, Protalix BioTherapeutics, Inc. (NYSE:PLX)...
By John Vandermosten, CFANYSE:PLXREAD THE FULL PLX RESEARCH REPORTProtalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals...